SCOTT MACDONALD: Open Payments
NPI 1720482086 · NORTH LOGAN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,210 in 77 payments from 19 companies in 2025. Trend: 2023 $1,032 · 2024 $1,185 · 2025 $1,210
Food & beverage: $1,210
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 15 | $163 |
| UCB, Inc. | 5 | $151 |
| Organon LLC | 12 | $149 |
| ABBVIE INC. | 12 | $137 |
| Novartis Pharmaceuticals Corporation | 6 | $119 |
| Janssen Biotech, Inc. | 4 | $84 |
| PFIZER INC. | 4 | $75 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $71 |
| GENZYME CORPORATION | 2 | $42 |
| Lilly USA, LLC | 2 | $41 |
Products named: NEMLUVIO, Bimzelx, SKYRIZI, TREMFYA, LITFULO, ILUMYA, COSENTYX, VTAMA.
Industry payments across UT — which companies pay providers there.
